From Atlanta, at a meeting of the American Society of Hematology
Researchers can now tag individual malignant cells in the bone marrow of patients with acute myeloid leukemia. Using an antibody that latches on to a newfound marker on the surface of the cancerous cells, the scientists can assess the cells’ abundance following chemotherapy and predict how well each patient will fare.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.